潜伏期 发表于 2025-3-25 06:43:17

Submitted on: 22 April 2003.
Revised on: 18 May 2003.
Accepted on: 24 May 2003.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

verdict 发表于 2025-3-25 07:43:21

http://reply.papertrans.cn/3/272/27195/27195-22.png

mitten 发表于 2025-3-25 14:00:26

http://reply.papertrans.cn/3/272/27195/27195-23.png

chastise 发表于 2025-3-25 19:17:06

Submitted on: 17 April 2001.
Revised on: 06 May 2001.
Accepted on: 21 May 2001.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Accord 发表于 2025-3-25 21:26:53

Submitted on: 12 August 2018.
Revised on: 22 August 2018.
Accepted on: 28 August 2018.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

intolerance 发表于 2025-3-26 03:57:14

Submitted on: 11 January 2014.
Revised on: 21 February 2014.
Accepted on: 04 March 2014.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

常到 发表于 2025-3-26 08:02:06

Submitted on: 09 August 2016.
Revised on: 15 September 2016.
Accepted on: 10 October 2016.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

主动 发表于 2025-3-26 11:01:01

http://reply.papertrans.cn/3/272/27195/27195-28.png

骑师 发表于 2025-3-26 16:29:43

Submitted on: 31 May 2010.
Revised on: 12 June 2010.
Accepted on: 21 June 2010.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Immunoglobulin 发表于 2025-3-26 18:53:32

http://reply.papertrans.cn/3/272/27195/27195-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊RHEUMATIC DISEASE CLINICS OF NORTH AMERICA 2024/2025影响因子:2.623 (RHEUM DIS CLIN N AM) (0889-857X). (RHEUMATOLOGY)(